Utilize este identificador para referenciar este registo:
https://hdl.handle.net/1822/37756Registo completo
| Campo DC | Valor | Idioma |
|---|---|---|
| dc.contributor.author | Oliveira, Hugo Alexandre Mendes | por |
| dc.contributor.author | Sillankorva, Sanna | por |
| dc.contributor.author | Merabishvili, Maia | por |
| dc.contributor.author | Kluskens, Leon | por |
| dc.contributor.author | Azeredo, Joana | por |
| dc.date.accessioned | 2015-10-26T11:32:32Z | - |
| dc.date.available | 2015-10-26T11:32:32Z | - |
| dc.date.issued | 2015-09 | - |
| dc.date.submitted | 2015-05 | - |
| dc.identifier.citation | Oliveira, Hugo; Sillankorva, Sanna; Merabishvili, Maia; Kluskens, Leon; Azeredo, Joana, Unexploited opportunities for phage therapy. Frontiers in Pharmacology, 6(180), 1-4, 2015 | por |
| dc.identifier.issn | 1663-9812 | por |
| dc.identifier.uri | https://hdl.handle.net/1822/37756 | - |
| dc.description.abstract | This opinion article reports on a number of bacterial pathogens for which virulent phages can still be isolated but till now have been neglected due to various reasons listed below. | por |
| dc.description.sponsorship | Project “BioHealth - Biotechnology and Bioengineering approaches to improve health quality,” Ref. NORTE-07-0124-FEDER-000027, co-funded by the Programa Operacional Regional do Norte (ON.2 – O Novo Norte), QREN, FEDER. Project “Consolidating Research Expertise and Resources on Cellular and Molecular Biotechnology at CEB/IBB,” Ref. FCOMP-01-0124- FEDER-027462 | por |
| dc.language.iso | eng | por |
| dc.publisher | Frontiers Media | por |
| dc.rights | openAccess | por |
| dc.subject | Bacteriophage therapy | por |
| dc.subject | Bacterial pathogens | por |
| dc.subject | Infectious diseases | por |
| dc.subject | Novel lytic bacteriophages | por |
| dc.subject | Antibiotic resistance | por |
| dc.title | Unexploited opportunities for phage therapy | por |
| dc.type | journalEditorial | - |
| dc.peerreviewed | yes | por |
| dc.relation.publisherversion | http://journal.frontiersin.org/article/10.3389/fphar.2015.00180/full | por |
| dc.comments | CEB22380 | por |
| sdum.publicationstatus | published | por |
| oaire.citationStartPage | 1 | por |
| oaire.citationEndPage | 4 | por |
| oaire.citationIssue | 180 | por |
| oaire.citationConferencePlace | France | - |
| oaire.citationTitle | Frontiers in Pharmacology | por |
| oaire.citationVolume | 6 | por |
| dc.date.updated | 2015-09-21T20:30:16Z | - |
| dc.identifier.doi | 10.3389/fphar.2015.00180 | por |
| dc.subject.fos | Ciências Médicas::Biotecnologia Médica | por |
| dc.subject.wos | Science & Technology | por |
| sdum.journal | Frontiers in Pharmacology | por |
| Aparece nas coleções: | ||
Ficheiros deste registo:
| Ficheiro | Descrição | Tamanho | Formato | |
|---|---|---|---|---|
| document_22380_1.pdf | 446,33 kB | Adobe PDF | Ver/Abrir |
